Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose metformin may help hair regrowth and reduce inflammation in CCCA.

Black women with CCCA are more likely to have uterine fibroids.

Topical metformin 10% cream may help treat central centrifugal cicatricial alopecia.

Using a special skin cream with gabapentin helped reduce symptoms of a certain scalp condition but didn't change nerve fibers or skin chemicals.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.

The letter suggests that the study's comparison group might have affected the results and calls for larger, more detailed future research.

Wearing a high-quality wig improved a woman's mood and life quality, and the authors suggest insurance should cover the cost of wigs.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

More research is needed on CCCA in children, especially Black and Asian adolescents.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

The authors maintain there is a significant link between vitamin D deficiency and central centrifugal cicatricial alopecia in Black patients, and call for more research on the topic.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Accurate diagnosis is crucial for effective treatment of hair loss.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

CCCA and lichen planopilaris have similar histological features, making them hard to distinguish.

CCCA can affect both genders and all ages, and it has a genetic component.

A woman's severe hair loss was caused by scalp psoriasis, not the initially thought condition, and treatment improved her psoriasis but couldn't restore her lost hair.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Enlarged sweat gland ducts may indicate scarring hair loss.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Using dermoscopy improves diagnosis of scalp and hair disorders in children.

DNA analysis can help tailor alopecia treatment.

Blood cell counts could help predict and treat alopecia areata and telogen effluvium.

Possible causes of female hair loss include androgenetic alopecia, telogen effluvium, cicatricial alopecia, and alopecia areata incognita; diagnosis and treatment require dermoscopy and histopathology.